Montebello, Mark

Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial

Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 266

A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal

CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 74

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines

Lintzeris, N., Monds, L. A., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., Walters, C., Galea, S., White, N., Montebello, M., et al. (2018) · Journal of Addiction Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 34

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

Bhardwaj, A. K., Mills, L., Doyle, M., Sahid, A., Montebello, M., Monds, L., Arunogiri, S., Haber, P., Lorenzetti, V., Lubman, D. I., et al. (2024) · BMC Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 10